GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ProMIS Neurosciences Inc (TSX:PMN) » Definitions » Price-to-Funds-From-Operations

ProMIS Neurosciences (TSX:PMN) Price-to-Funds-From-Operations : (As of May. 06, 2024)


View and export this data going back to 2005. Start your Free Trial

What is ProMIS Neurosciences Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


ProMIS Neurosciences (TSX:PMN) Business Description

Traded in Other Exchanges
Address
1920 Yonge Street, Suite 200, Toronto, ON, CAN, M4S 3E2
ProMIS Neurosciences Inc is focused on the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases, including Alzheimer's disease, amyotrophic lateral sclerosis, and multiple system atrophy. The company also plans to investigate additional synucleionapathies, including Parkinson's disease, and dementia with Lewy bodies. It operates in Canada.